Furthermore, in pancreatic cancer, L1CAM promotes, via α5-integrin para- or autocrine signaling of IL1β, which induces iNOS activation and NOS secretion, leading to the inhibition of caspase 3 and 7 activity [58,59]. Here, CASP3 is linked to pancreatic neoplasm.